```html

Xerophthalmia‑Related Blurred Vision

What is Xerophthalmia‑related blurred vision?

Xerophthalmia is a medical term that describes severe dryness of the ocular surface, usually caused by a deficiency of vitamin A or by chronic damage to the tear‑film-producing glands. When the surface of the eye becomes too dry, the cornea and conjunctiva lose their smooth, refractive quality, leading to blurred vision. This visual disturbance can be intermittent or constant, mild or severe, and is often a warning sign that the eye’s protective mechanisms are failing.

In simple terms, xerophthalmia‑related blurred vision means “your vision is foggy because the eye is not lubricated enough.” The condition can affect anyone, but it is most common in individuals with:

• Vitamin A deficiency (e.g., malnutrition, malabsorption syndromes)
• Severe dry‑eye disease (keratoconjunctivitis sicca)
• Chronic use of topical or systemic medications that reduce tear production

While the word “xerophthalmia” is often associated with the extreme end of the dry‑eye spectrum (such as Bitot’s spots and corneal ulceration), even milder forms can produce noticeable visual blur.

Common Causes

The following conditions or factors commonly lead to xerophthalmia‑related blurred vision. Some are nutritional, others are environmental or iatrogenic.

• Vitamin A deficiency – inadequate dietary intake, fat‑malabsorption disorders (celiac disease, cystic fibrosis) or chronic liver disease.<sup>1</sup>
• Sjögren’s syndrome – an autoimmune disease that attacks the lacrimal and salivary glands, causing severe dry eye.
• Meibomian gland dysfunction (MGD) – blockage of oil‑secreting glands leads to rapid tear evaporation.
• Chronic blepharitis – inflammation of the eyelid margin compromises tear spread.
• Topical antihistamine or glaucoma drops – preservatives (benzalkonium chloride) can be toxic to the ocular surface.
• Systemic medications – antihistamines, isotretinoin, antihypertensives, antidepressants, and antihistamines for allergies can reduce tear secretion.
• Environmental exposure – low humidity, wind, air‑conditioning, and prolonged screen time increase tear evaporation.
• Contact lens wear – especially extended‑wear lenses, can disrupt tear film stability.
• Radiation therapy or chemotherapy – damage to goblet cells and lacrimal glands.
• Age‑related changes – tear production naturally declines after age 50, predisposing older adults to xerophthalmia.

Associated Symptoms

Blurred vision caused by xerophthalmia rarely occurs in isolation. Patients commonly report the following accompanying signs:

• Grittiness or foreign‑body sensation (“sand in the eye”)
• Burning, stinging, or itching
• Redness of the conjunctiva
• Watery tearing (reflex tearing that paradoxically worsens dryness)
• Photophobia (sensitivity to light)
• Morning crusting on the eyelashes or eyelids
• Feeling of eyelid swelling or heaviness
• Fluctuating vision that improves after blinking
• Night‑time vision problems, especially when the tear film is thinner.

When to See a Doctor

Because the eye’s surface is essential for clear vision, prompt evaluation is important. Seek medical attention if you notice any of the following:

• Blurred vision that does not improve after blinking or using artificial tears.
• Persistent redness or pain lasting more than 48 hours.
• Development of white or yellow‑ish patches on the conjunctiva (Bitot’s spots) or on the cornea.
• Sudden worsening of vision, especially if you also have eye pain.
• History of Vitamin A deficiency, malnutrition, or chronic gastrointestinal disease.
• Use of multiple ophthalmic drops and new symptoms appear.

Diagnosis

Eye specialists (ophthalmologists or optometrists) use a combination of history, examination, and specialized tests to confirm xerophthalmia‑related blurred vision.

Clinical History

• Dietary intake and nutritional status.
• Medication list (including over‑the‑counter eye drops).
• Systemic diseases (autoimmune, hepatic, gastrointestinal).
• Occupational and environmental exposure.

Ocular Surface Examination

• Slit‑lamp biomicroscopy – visualizes corneal epithelium, tear film break‑up time (TBUT), and presence of punctate keratitis.
• Fluorescein staining – highlights areas of epithelial damage; a “patchy” pattern is typical of dry‑eye‑induced blur.
• Schirmer test – measures basal tear production (≤5 mm in 5 min suggests severe dryness).
• Meibography – imaging of meibomian glands to assess dysfunction.

Laboratory & Imaging Studies (if indicated)

• Serum retinol (vitamin A) level – low levels confirm deficiency.<sup>2</sup>
• Autoimmune panels (ANA, SSA/SSB) for Sjögren’s syndrome.
• Liver function tests and lipid profile for malabsorption causes.

Treatment Options

Treatment aims to restore a stable tear film, address the underlying cause, and protect the cornea.

Medical Therapies

• Artificial tears – preservative‑free lubricants used 4–6 times daily; hyaluronic acid formulations provide longer residence time.
• Prescription lubricating drops – e.g., cyclosporine 0.05% (Restasis®) or lifitegrast 5% (Xiidra®) to increase tear production.
• Vitamin A supplementation – oral retinol 10,000–25,000 IU daily for deficiency, or high‑dose intramuscular injections in severe cases (under physician supervision).<sup>3</sup>
• Punctal plugs – silicone or collagen plugs inserted into tear ducts to retain tears.
• Topical antibiotics or anti‑inflammatory agents – for secondary bacterial keratitis or severe inflammation.
• Systemic immunomodulators – for autoimmune causes (hydroxychloroquine for Sjögren’s, but only under specialist care).
• Warm compresses & lid hygiene – essential for MGD; use a warm eye mask for 5–10 minutes, followed by gentle lid scrubs.

Home & Lifestyle Measures

• Increase ambient humidity (humidifier, especially at night).
• Take regular breaks during screen use (20‑20‑20 rule: every 20 minutes look at something 20 feet away for 20 seconds).
• Avoid direct airflow from fans, hairdryers, or air‑conditioners toward the eyes.
• Stay well‑hydrated; drink 2–3 L of water per day unless contraindicated.
• Wear wrap‑around sunglasses outdoors to reduce evaporation.
• Consume a diet rich in vitamin A (carrots, sweet potatoes, leafy greens, liver) and omega‑3 fatty acids (flaxseed, fish oil) to support tear quality.

Follow‑up Care

Patients should be re‑evaluated every 4–6 weeks after initiating therapy, or sooner if symptoms worsen. Objective measures (TBUT, Schirmer) and visual acuity are tracked to gauge response.

Prevention Tips

While some risk factors (age, genetics) cannot be changed, many practical steps can reduce the likelihood of xerophthalmia‑related blurred vision.

• Balanced nutrition – ensure adequate intake of vitamin A, vitamin D, and essential fatty acids.
• Screen hygiene – use blue‑light filters, keep screens at proper distance, and blink consciously.
• Limit preservative‑rich eye drops – choose preservative‑free options for chronic use.
• Regular eye exams – especially for people with autoimmune disease, diabetes, or on systemic medications that affect tear production.
• Control environmental factors – use a humidifier in dry climates; avoid smoking, which worsens tear evaporation.
• Manage systemic disease – proper treatment of gastrointestinal malabsorption, liver disease, or thyroid disorders helps maintain adequate vitamin A levels.

Emergency Warning Signs

---

References:

1. Mayo Clinic. Vitamin A deficiency. 2023. https://www.mayoclinic.org
2. National Institutes of Health, Office of Dietary Supplements. Vitamin A Fact Sheet. 2022.
3. World Health Organization. Prevention of Blindness from Vitamin A Deficiency. 2021.
4. Cleveland Clinic. Dry Eye (Keratoconjunctivitis Sicca). 2024.
5. American Academy of Ophthalmology. Management of Meibomian Gland Dysfunction. 2023.

```